Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine
Aguilar-Toal, A
Sicard, F., Vogeleer, P., Bihan, G
, Panthenol, Hydroxyacetophenone, Glyceryl Stearate, Peg-100 Stearate, 1,2-hexanediol, Betaine, Cellulose Gum, Shea Butter, Caprylyl Glycol, Potassium Chloride, Sodium Polyacrylate, Poly Glyceryl-10 Laurate, Polysorbate 60, Hydrogenated Polydecene, Sucrose, Butylene Glycol, Hydrogenated Lecithin, Trideceth-6, Pantolactone, Dipotassium Glycyrrhizate, Polyglyceryl-3methylglucose Distearate, Centella Asiatica Extract, Japanese Knotweed Root Extract, Goldenrod Extract, Peony Root Extract, Matricaria Flower Extract, Green Tea Extract, Arginine, Carbomer, Spanish Licorice Root Extract, Glyceryl Caprylate , Rosemary Leaf Extract, Adenosine, Ethylhexylglycerin, Camellia Seed Oil, Evening Primrose Oil, Rosehip Fruit Oil, Mud Mushroom Extract, Kelp Extract, Disodium Edta

Product Details Product Name: MOTS-C 10mg Form: Lyophilized powder Purity: 99% (HPLC verified) Molecular Weight: ~2174.5 Da CAS Number: 1627580-64-6 Packaging: Sterile sealed vial Storage: Store in a cool, dry place Intended Use: For laboratory research use only Notice: This material is supplied strictly for research purposes only